Sun Pharmaceutical Industries Ltd. Financials: Quarterly Results
Revenue
16047.91
Cr.
PAT
3401.09
Cr.
EBITDA
4795
Cr.
Sun Pharmaceutical Industries Ltd. Q3FY26 Financial Metrics
| Indicator | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 15469.07 | 14405.22 | 13786.07 | 12815.58 | 13436.94 |
| Total Income From Operations (Cr.) | 15520.54 | 14478.31 | 13851.40 | 12958.84 | 13675.46 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 4795 | 4267.47 | 4065.57 | 3665.17 | 3844.08 |
| P/L Before Exceptional Items & Tax (Cr.) | 4716.64 | 4167.61 | 3990.77 | 3616.03 | 3792.57 |
| P/L After Tax from Ordinary Activities (Cr.) | 3401.09 | 3137.09 | 2302.62 | 2160.64 | 2917.54 |
| Net Profit/Loss For the Period (Cr.) | 3401.09 | 3137.09 | 2302.62 | 2160.64 | 2917.54 |
| Basic EPS | 14 | 13 | 9.50 | 9 | 12.10 |
FAQs
Sun Pharmaceutical Industries Ltd. announced its quarterly results for Q3 FY2026 on February 2, 2026.
In Q3 FY2026, Sun Pharmaceutical Industries Ltd. are as follows:
Revenue: ₹16047.91 crore
Net Profit: ₹3401.09 crore.
For Q3 FY2026, Sun Pharmaceutical Industries Ltd. posted ₹16047.91 crore in revenue and ₹3401.09 crore in net profit.
Past quarterly results for Sun Pharmaceutical Industries Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.